DUBLIN--(BUSINESS WIRE)--The "Global Next Generation Sequencing (NGS) Market Growth, Trends & Forecasts (2016 - 2021)" report has been added to Research and Markets' offering.
The Global Market for Next Generation Sequencing is poised to reach $10 billion by the end of 2020 growing at a CAGR of approximately 20%.
The instruments and consumables is the largest segment with a share of around half of the market in 2013. The fastest growing segment is the services with a highest CAGR during the forecast period. The major players are interested in services segment as it provides additional revenue for the company at the same time, increases the sales of instruments and reagents.
Increasing applications in clinical diagnosis boosting the market growth, speed, cost and accuracy to spur the market growth, Efficient replacement for traditional technologies (Microarrays), and drug discovery applications demanding NGS technology are the major factors driving the growth of the market.
Companies Mentioned
- Roche Holding Ag
- Agilent Technologies
- BGI (Beijing Genomics Institute)
- Biomatters
- Qiagen
- Dnastar
- Gatc Biotech Ag
- Genomatix Software Gmbh
- Illumina
- Knome
- Thermo Fisher Scientific
- Macrogen
- Oxford Nanopore Technologies
- Pacific Biosciences
- Parte
Key Topics Covered:
- Introduction
-
Research Methodology
-
Executive Summary
-
Key Inferences
-
Market Overview and Industry Trends
-
Drivers, Restraints and Opportunities
-
Global Next Generation Sequencing (NGS) Market Segmentation
-
Global Next Generation Sequencing (NGS) Market Segmentation By
Geography
-
Analyst Outlook For Investment Opportunities
-
Future Outlook of the Market
- Appendix
For more information about this report visit https://www.researchandmarkets.com/research/mxvgw6/global_next
